IMMUNOVANT, INC. — Key Metrics
1 years of history · ending 2024-03-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-2
Book Value Per Share
$4
Free Cash Flow Per Share
$-2
Cash Per Share
$5
Revenue Per Share
$0
OCF Per Share
$-2
Return on Equity
-52.9%
Return on Assets
-48.4%
Current Ratio
13.70
Quick Ratio
13.70
Asset Turnover
0.05
Days Sales Outstanding
78.08
R&D / Revenue
853.5%
SBC / Revenue
164.8%
Capex / Revenue
1.4%
Working Capital
$617M
Net Current Asset Value
$617M
Invested Capital
$618M
OCF / Net Income
0.83
FCF / Net Income
0.83
Accruals Ratio (Sloan)
-6.8%
Net Debt
$-635M
Net Debt / EBITDA
-2750.50
Cash Coverage
-8.59
Capex Coverage
-595.08
Tangible Common Equity
$618M
TCE / Total Assets
92.7%
Cash ROIC
-43.8%
WC / Revenue
2473.8%
Capex / D&A
1.56
Asset Growth vs Revenue Growth
-165.0%
EBITDA 5Y CAGR
87.4%
Book Value 5Y CAGR
142.7%
Stock Price (FY-end)
$32
Market Cap
$4.46B
P/S Ratio
178.85
P/B Ratio
7.22
P/TB Ratio
7.22
Enterprise Value
$3.83B
EV / EBITDA
16565.65
EV / Sales
153.39
FCF Yield
-4.8%
Shareholder Yield
-0.9%
R&D Yield
4.8%
Capex Yield
0.0%
Shares Variation (YoY)
12.2%
Beta (5Y)
0.89
Cost of Equity
9.0%
52W High
$44
52W Low
$14
Trailing Return 1Y
108.5%
Trailing Return 5Y
—
F-Score (Piotroski)
4.00
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.